Day: April 24, 2022

In 2020, it approved Epidiolex for the treatment of seizures associated with tuberous sclerosis complex. Epidiolex was the agency’s first approval of a drug derived from cannabis and has paved the way for the development of more CBD-based medicines to treat medical conditions. The first tests on the use of CBD in the treatment of…